Factors often not considered before a multicenter trial is started
Clin Pharmacol Ther
.
1996 Aug;60(2):121-3.
doi: 10.1016/S0009-9236(96)90126-5.
Author
E Hardy
1
Affiliation
1
Department of Obstetrics and Gynecology, Faculty of Medical Sciences, Universidade Estadual de Campinas, Säo Paulo, Brazil.
PMID:
8823229
DOI:
10.1016/S0009-9236(96)90126-5
No abstract available
MeSH terms
Humans
Informed Consent
Multicenter Studies as Topic / standards*
Research Design
Sample Size
Writing